Gideon Bollag

Also affiliated with Mission Bio (United States)

Biochemistry, Genetics and Molecular BiologyMedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “BET inhibition reforms the immune microenvironment and alleviates T cell dysfunction in chronic lymphocytic leukemia”.

BET inhibition reforms the immune microenvironment and alleviates T cell dysfunction in chronic lymphocytic leukemia

JCI Insight(2024)10.1172/jci.insight.177054

N/A

0.460DataRank · unranked

11 citations

Sydney A. Skupa, Alexandria P. Eiken, Timothy E. Reznicek, Elizabeth Schmitz, Nolan Williams +14 more

Uterine leiomyosarcomas harboring MAP2K4 gene amplification are sensitive in vivo to PLX8725, a novel MAP2K4 inhibitor

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.03.009

N/A

0.241DataRank · unranked

4 citations

Justin Harold, Diego Manavella, Stefania Bellone, Levent Mutlu, Tobias M.P. Hartwich +24 more

Targeting TAZ-TEAD in minimal residual disease enhances the duration of targeted therapy in melanoma models

Nature Communications(2025)10.1038/s41467-025-64682-7

N/A

0.170DataRank · unranked

2 citations

Timothy J. Purwin, Panyu Chen, Somenath Chowdhury, George L. Mellor, K.X. Luo +10 more

Data from Response and Resistance to Paradox-Breaking BRAF Inhibitor in Melanomas In Vivo and Ex Vivo

(2023)10.1158/1535-7163.c.6539317

N/A

0DataRank · unranked

0 citations

Curtis H. Kugel, Michael J. Vido, Adam C. Berger, Timothy J. Purwin, Allison Goldberg +6 more

Inhibition of Bromodomain and Extra Terminal (BET) Domain Activity Modulates the IL-23R/IL-17 Axis and Suppresses Acute Graft-Versus-Host Disease

Frontiers in Oncology(2021)10.3389/fonc.2021.760789

N/A

0DataRank · unranked

18 citations

Hannah Choe, Yandi Gao, Natalie E. Sell, Kara M. Braunreiter, Nina C. Zitzer +13 more

Acute Myeloid Leukemia Relapse after Bromodomain Inhibitor Treatment or Chemotherapy is Characterized by Myc-Ras Transcriptional Remodeling

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.11.13.688312

N/A

0DataRank · unranked

0 citations

Jeevitha D’Souza, Alexa Rane Batingana, Max Harris, Xinyue Wang, Eugene Hwang +7 more

Recurrent Mutations in Cyclin D3 Confer Clinical Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-3458

N/A

0DataRank · unranked

16 citations

Aaron D. Viny, Evan Massi, Cyriac Kandoth, Nicholas D. Socci, Franck Rapaport +12 more

Structural and functional analyses of a germline KRAS T50I mutation provide insights into Raf activation

JCI Insight(2023)10.1172/jci.insight.168445

N/A

0DataRank · unranked

6 citations

Benjamin J. Huang, Max Harris, Christopher Boone, Weijie Wang, Heidi Carias +8 more